Medical Editor: John P. Cunha, DO, FACOEP
Betoptic S (betaxolol hydrochloride ophthalmic suspension) is a beta-blocker that reduces pressure inside the eye used to treat open-angle glaucoma and other causes of high pressure inside the eye. Common side effects of Betoptic S include temporary stinging/burning/discomfort of the eye, watery/dry/itchy/red eyes, blurred vision, feeling as if something is in the eye, crusting of eyelashes, headache, trouble sleeping (insomnia), dizziness, spinning sensation, swollen or puffy eyes, depression, muscle weakness, or altered sense of taste or smell.
The recommended dose of Betoptic S is one drop instilled in the affected eye twice daily. It may be used alone or in combination with other intraocular pressure lowering medications. Betoptic S may interact with oral betaxolol, digoxin, reserpine, insulin or oral diabetes medications, other beta-blockers, calcium channel blockers, or medicines to treat psychiatric disorders. Tell your doctor all medications and supplements you use. During pregnancy, Betoptic S should be used only when prescribed. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.
Our Betoptic S (betaxolol hydrochloride ophthalmic suspension) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using this medication and call your doctor at once if you have any of these serious side effects:
- severe swelling, itching, burning, redness, pain, or discomfort in or around your eye;
- drainage, crusting, or oozing of your eyes or eyelids;
- bronchospasm (wheezing, chest tightness, trouble breathing);
- slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
- feeling short of breath, even with mild exertion; or
- swelling, rapid weight gain.
Less serious side effects may include:
- mild burning, stinging, itching, or discomfort of your eyes;
- dry eyes, blurred vision;
- mildly swollen or puffy eyes;
- feeling like something is in your eye;
- headache, dizziness, spinning sensation;
- sleep problems (insomnia);
- muscle weakness; or
- altered sense of taste or smell.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Betoptic S (Betaxolol Hydrochloride Ophthalmic Suspension)
Clinical Studies Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In clinical trials, the most frequent adverse reaction associated with the use of BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) Ophthalmic Suspension 0.25% has been transient ocular discomfort. The following other adverse reactions have been reported in small numbers of patients:
Ocular: blurred vision, corneal punctate keratitis, foreign body sensation, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, ocular pain, decreased visual acuity and crusty lashes.
In a 3-month, double-masked, active-controlled, multicenter study in pediatric patients, the adverse reaction profile of BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) Ophthalmic Suspension 0.25% was comparable to that seen in adult patients.
Additional Potential Adverse Reactions Associated with Betaxolol
Additional medical events reported with other formulations of betaxolol include allergic reactions, decreased corneal sensitivity, corneal punctate staining which may appear in dendritic formations, edema and anisocoria.
Read the entire FDA prescribing information for Betoptic S (Betaxolol Hydrochloride Ophthalmic Suspension)
© Betoptic S Patient Information is supplied by Cerner Multum, Inc. and Betoptic S Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.